- Home
- BANR vs CPRX Comparison
BANR vs CPRX Comparison
Compare BANR & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANR
- CPRX
- Stock Information
- Founded
- BANR 1890
- CPRX 2002
- Country
- BANR United States
- CPRX United States
- Employees
- BANR N/A
- CPRX N/A
- Industry
- BANR Major Banks
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- BANR Finance
- CPRX Health Care
- Exchange
- BANR Nasdaq
- CPRX Nasdaq
- Market Cap
- BANR 2.3B
- CPRX 2.5B
- IPO Year
- BANR 1995
- CPRX 2006
- Fundamental
- Price
- BANR $70.11
- CPRX $22.78
- Analyst Decision
- BANR Buy
- CPRX Strong Buy
- Analyst Count
- BANR 6
- CPRX 7
- Target Price
- BANR $66.60
- CPRX $32.86
- AVG Volume (30 Days)
- BANR 253.9K
- CPRX 1.4M
- Earning Date
- BANR 01-22-2025
- CPRX 02-26-2025
- Dividend Yield
- BANR 2.74%
- CPRX N/A
- EPS Growth
- BANR N/A
- CPRX 114.68
- EPS
- BANR 4.78
- CPRX 1.18
- Revenue
- BANR $593,391,000.00
- CPRX $460,482,000.00
- Revenue This Year
- BANR N/A
- CPRX $23.98
- Revenue Next Year
- BANR $4.11
- CPRX $18.27
- P/E Ratio
- BANR $14.67
- CPRX $19.33
- Revenue Growth
- BANR N/A
- CPRX 32.17
- 52 Week Low
- BANR $42.00
- CPRX $13.12
- 52 Week High
- BANR $78.05
- CPRX $24.27
- Technical
- Relative Strength Index (RSI)
- BANR 56.02
- CPRX 56.81
- Support Level
- BANR $68.88
- CPRX $21.23
- Resistance Level
- BANR $72.03
- CPRX $23.26
- Average True Range (ATR)
- BANR 1.82
- CPRX 1.14
- MACD
- BANR 0.57
- CPRX 0.20
- Stochastic Oscillator
- BANR 77.75
- CPRX 74.85
About BANR Banner Corporation
Banner Corp is a bank holding company. It wholly owns one subsidiary bank, Banner Bank. The Bank's primary business is that of traditional banking institutions, accepting deposits and originating loans in locations surrounding its offices in Washington, Oregon, California, Idaho and Utah. Banner Bank also actively participates in the secondary loan markets, engaging in mortgage banking operations largely through the origination and sale of one to four family residential loans.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.